Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab.
Best source
All available sources
- Authors:
- Nicholas, Jacqueline
Belviso, Nick
Banerjee, Geentanjoli
Geremakis, Caroline
Avila, Robin
Bodhinathan, Karthik - Source:
- Multiple Sclerosis & Related Disorders; Mar2022, Vol. 59, pN.PAG-N.PAG, 1p
- Publication Date:
- 2022-03-01
- Language:
- English
- Format:
- Academic Journal
- DOI:
- 10.1016/j.msard.2022.103628
- Database:
- Supplemental Index
- Journal:
- Multiple Sclerosis & Related Disorders
- Volume:
- 59
- Page Start:
- N.PAG
- Page Count:
- 1
- ISSN:
- 22110348
